vs
Side-by-side financial comparison of BioNTech SE (BNTX) and Dole plc (DOLE). Click either name above to swap in a different company.
Dole plc is the larger business by last-quarter revenue ($2.3B vs $1.5B, roughly 1.5× BioNTech SE). Dole plc runs the higher net margin — 0.2% vs -1.9%, a 2.1% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Dole plc is an Irish-American agricultural multinational corporation headquartered in Dublin, Ireland. The company is among the world's largest producers of fruit and vegetables, operating with 38,500 full-time and seasonal employees who supply some 300 products in 75 countries. Dole reported 2021 revenues of $6.5 billion.
BNTX vs DOLE — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $2.3B |
| Net Profit | $-28.7M | $5.1M |
| Gross Margin | — | 6.8% |
| Operating Margin | -3.1% | 1.1% |
| Net Margin | -1.9% | 0.2% |
| Revenue YoY | — | 10.5% |
| Net Profit YoY | — | -64.6% |
| EPS (diluted) | — | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $1.5B | $2.3B | ||
| Q2 25 | $260.8M | $2.4B | ||
| Q1 25 | — | $2.1B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.1B | ||
| Q3 23 | — | $2.0B | ||
| Q2 23 | — | $2.1B |
| Q3 25 | $-28.7M | $5.1M | ||
| Q2 25 | $-386.6M | $10.0M | ||
| Q1 25 | — | $38.9M | ||
| Q3 24 | $198.1M | $14.4M | ||
| Q2 24 | — | $80.1M | ||
| Q1 24 | — | $70.1M | ||
| Q3 23 | — | $45.3M | ||
| Q2 23 | — | $42.3M |
| Q3 25 | — | 6.8% | ||
| Q2 25 | — | 9.0% | ||
| Q1 25 | — | 8.7% | ||
| Q3 24 | — | 8.0% | ||
| Q2 24 | — | 9.4% | ||
| Q1 24 | — | 9.2% | ||
| Q3 23 | — | 8.1% | ||
| Q2 23 | — | 9.2% |
| Q3 25 | -3.1% | 1.1% | ||
| Q2 25 | -192.1% | 4.3% | ||
| Q1 25 | — | 3.2% | ||
| Q3 24 | 0.8% | 2.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 5.3% | ||
| Q3 23 | — | 3.8% | ||
| Q2 23 | — | 4.3% |
| Q3 25 | -1.9% | 0.2% | ||
| Q2 25 | -148.2% | 0.4% | ||
| Q1 25 | — | 1.9% | ||
| Q3 24 | 15.9% | 0.7% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | 3.3% | ||
| Q3 23 | — | 2.2% | ||
| Q2 23 | — | 2.0% |
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $0.41 | ||
| Q3 24 | — | $0.15 | ||
| Q2 24 | — | $0.84 | ||
| Q1 24 | — | $0.74 | ||
| Q3 23 | — | $0.48 | ||
| Q2 23 | — | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $321.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $1.4B |
| Total Assets | — | $4.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $321.0M | ||
| Q2 25 | — | $323.1M | ||
| Q1 25 | — | $261.0M | ||
| Q3 24 | — | $266.4M | ||
| Q2 24 | — | $225.8M | ||
| Q1 24 | — | $245.5M | ||
| Q3 23 | — | $223.3M | ||
| Q2 23 | — | $236.8M |
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.3B | ||
| Q3 23 | — | $1.2B | ||
| Q2 23 | — | $1.2B |
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.7B | ||
| Q1 25 | — | $4.5B | ||
| Q3 24 | — | $4.5B | ||
| Q2 24 | — | $4.4B | ||
| Q1 24 | — | $4.5B | ||
| Q3 23 | — | $4.5B | ||
| Q2 23 | — | $4.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $87.4M |
| Free Cash FlowOCF − Capex | — | $66.5M |
| FCF MarginFCF / Revenue | — | 2.9% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 17.12× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.7M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $87.4M | ||
| Q2 25 | — | $18.3M | ||
| Q1 25 | — | $-78.8M | ||
| Q3 24 | — | $101.0M | ||
| Q2 24 | — | $40.2M | ||
| Q1 24 | — | $-35.0M | ||
| Q3 23 | — | $80.4M | ||
| Q2 23 | — | $58.6M |
| Q3 25 | — | $66.5M | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-131.6M | ||
| Q3 24 | — | $79.9M | ||
| Q2 24 | — | $22.8M | ||
| Q1 24 | — | $-53.2M | ||
| Q3 23 | — | $64.7M | ||
| Q2 23 | — | $40.6M |
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | -0.0% | ||
| Q1 25 | — | -6.3% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | -2.5% | ||
| Q3 23 | — | 3.2% | ||
| Q2 23 | — | 1.9% |
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 2.5% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.9% | ||
| Q3 23 | — | 0.8% | ||
| Q2 23 | — | 0.8% |
| Q3 25 | — | 17.12× | ||
| Q2 25 | — | 1.84× | ||
| Q1 25 | — | -2.02× | ||
| Q3 24 | — | 7.01× | ||
| Q2 24 | — | 0.50× | ||
| Q1 24 | — | -0.50× | ||
| Q3 23 | — | 1.77× | ||
| Q2 23 | — | 1.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
